InvestorsHub Logo
Followers 144
Posts 27603
Boards Moderated 3
Alias Born 02/07/2004

Re: None

Thursday, 06/16/2005 8:51:52 AM

Thursday, June 16, 2005 8:51:52 AM

Post# of 229
Compugen to Present at the BIO 2005 Annual International Convention
Thursday June 16, 8:49 am ET


TEL AVIV, Israel--(BUSINESS WIRE)--June 16, 2005--Compugen Ltd. (NASDAQ: CGEN - News) announced today that representatives of the Company are scheduled to present in two sessions at the BIO 2005 Annual International Convention in Philadelphia, PA. Martin Gerstel, Compugen's Chairman of the Board will chair a session titled "Life Science is from Venus, the Financial Community is from Mars: Part Two" on Monday, June 20 at 4:00 PM Eastern Daylight Time. Salomon Langer, M.D., Senior Vice President, Drug Discovery will chair a session in the drug discovery and development track titled "Discovery Engines and Other Strategies to Improve Productivity of Drug Discovery" on Tuesday, June 21 at 4:00 PM Eastern Daylight Time.
About Compugen

Compugen is a drug and diagnostic discovery company incorporating ideas and methods from mathematics, computer science, and physics into biology, chemistry and medicine. The Company's powerful predictive models and discovery engines are both advancing the understanding of important biological phenomena and enabling the discovery of numerous potential therapeutic products and diagnostic markers. The Company has an early stage in-house pipeline consisting of selected therapeutic protein candidates discovered by the Company; additional discoveries have been out-licensed for development. Among Compugen's customers and partners are leading pharmaceutical and diagnostic companies, such as Abbott Laboratories, Diagnostic Products Corporation, Novartis, and Pfizer. Compugen has established a small-molecule drug discovery affiliate - Keddem Bioscience, and an agricultural biotechnology affiliate - Evogene. For additional information, please visit Compugen's corporate Website at www.cgen.com.



--------------------------------------------------------------------------------
Contact:
Compugen:
Director, Corporate Communications
Tsipi Haitovsky, +972-52-5989892
tsipi@cgen.com
or
The Ruth Group:
investors:
John Quirk, 646-536-7029
jquirk@theruthgroup.com
or
media:
Zack Kubow, 646-536-7020
zkubow@theruthgroup.com



--------------------------------------------------------------------------------
Source: Compugen Ltd.

Dubi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CGEN News